Based on the structure-activity relationship data of BMY-28864 and related pradimicin derivatives, the calcium salt-forming ability and the D-mannopyranoside-speciflc visible absorption maximumshift of BMY-28864 were analysed in the ternary complex formation of BMY-28864 with D-mannopyranoside and calcium. The free C-18 carboxyl group of BMY-28864 was proved to be the sole site for binding to calcium, while no hydroxyl groups of the aglycone were involved in calcium salt formation. The stereospecific D-mannopyranoside-recognizing ability of BMY-28864 was completely abolished by removal of the C-5 disaccharide moiety, and, more particularly, of the C-5 thomosaminemoiety. Close relationship of these findings with the antifungal action was also supported by the in vitro antifungal assay and the potassium leakage induction test.
In previous papers1~4), the in vitro antifungal activities of pradimicin and benanomicin derivatives on yeasts were shown to be specifically expressed only in the presence of calcium. Using BMY-28864, a water-soluble pradimicin derivative, specific binding of the pradimicin to yeast cells was proved to depend on the ternary complex formation of BMY-28864with mannan and calcium at a molar ratio of 2 :4 : 15). This highly stereospecific binding of BMY-28864 to the mannose unit (more generally, the specific sugar-recognizing ability of the pradimicin and benanomicin family of antibiotics) is biochemically worth studying, as it is currently unexplicable by the widely accepted concepts of receptor-ligand binding in the light of lectin and carbohydrate sciences. Lectins have been considered to recognize specific sugars based on the intrinsic properties of their peptide components, whereas the pradimicin and benanomicin family of compounds are not peptides. Under these circumstances, it is crucially important and essential to more precisely elucidate the mechanismof ternary complexformation of pradimicins with specific sugars and calcium in critical comparison with lectins. This type of knowledge is not only biochemically useful for receptology, but also clinically important from the viewpoint of selective toxicity of final pradimicin drugs in hosts, as sugars are essential cellular components of host animals to be treated with pradimicin, and assumed to exist ubiquitously at significant concentrations in a variety of forms throughout therapy.
In this paper, the structure-activity relationship of BMY-28864 and related pradimicin derivatives is analyzed for identification of the moieties of BMY-28864responsible for binding to D-mannopyranoside and calcium and for induction of the visible absorption maximumshift. In brief, only the free C-18 carboxyl group of BMY-28864serves to bind to calcium as salt, while the C-5 disaccharide moiety is essential for specific recognition of and binding to D-mannopyranoside. Correspondence should be addressed to Jun Okumura, Bristol-Myers Squibb Research Institute, 2-9-3 Shimomeguro, Meguro-ku, Tokyo 153, Japan.
Materials and Methods
Fermentation and Isolation of BMY-28567and Pradimicin Analogs MAR. 1993 BMY-28567(pradimicin A) and other pradimicin analogs as starting materials for chemical synthesis of pradimicin derivatives were produced by fermentation and isolated as reported in a previous paper6).
Influences of Incubation Conditions on the Visible Absorption Peak of BMY-28864 Incubation pH: Reaction mixtures which contained 100 fiM BMY-28864with or without 1 mMcalcium chloride at the indicated pH's were incubated at 30°C for 30 minutes. After incubation, the reaction mixtures were centrifuged at 14,000 rpm for 5 minutes. The supernatants were employed for determination of the visible absorption maximumof BMY-28864by scanning visible spectrophotometry (400^600 nm) with a Beckman DU-70 UV-visible spectrophotometer.
Incubation Temperature: BMY-28864 (1.15 mM, 100//I), 200 /jl\ of 25 mg/ml yeast mannan (Product No. M7504, Sigma Chemical Co.), 690^1 of distilled water (pH 7.0) and 10^1 of 100mMCaCl2 were mixed and incubated for 30 minutes at the indicated temperatures for 30 minutes. Control tests were carried out without yeast mannanin the presence of 1 mMcalcium chloride. After incubation, the reaction mixtures were centrifuged at 14,000rpm for 5 minutes. The supernatants were subjected to scanning visible spectrophotometry in a wavelength range of 400 to 600 nm.
Calcium Concentration: Reaction mixtures contained 100/^m BMY-28864, 5 mg/ml yeast mannan and calcium chloride in a concentration range of 0.1 to 10mM.Control tests contained no yeast mannan. After incubation at 30°C for 30 minutes, the reaction mixtures were centrifuged at 14,000 rpm for 5 minutes. Thesupernatants were employedfor determination of the visible absorption maximum of BMY-28864 by scanning spectrophotometry from 400 to 600 nm.
Analytical Methods
UV-visible Spectrophotometric
Analysis: BMY-28S64 (1.15 niM, pH 7.0) was dissolved in distilled water or 50mM3-(ALmorpholino)-propanesulfonic acid (MOPS), pH 7.4. For interaction with mannan (Product No. M6882, Sigma Chemical Co.), lOOjul of 1.15mM BMY-28864 was mixed with 200/xl of lOmg/ml yeast mannan and 700 /il of distilled water or 50mMMOPS,pH 7.4, in the presence and absence of 1 mMcalcium chloride. After incubation at 30°C for 2 hours, the mixture was centrifuged for 5 minutes at 1 5,000 rpm and the supernatant was subjected to scanning UV-visible spectrophotometry in a wavelength range from 200 to 700nm.
For interaction with a variety of simple sugars, the final sugar concentrations were all set at 200mM, and the mixtures were centrifuged without incubation to give the supernatants which were analyzed by scanning UV-visible spectrophotometry.
Calcium Salt Formation: A pradimicin derivative (1.15mM, 100//I) was mixed with 100/A of 10mM calcium chloride and 800^1 of distilled water at pH 7.0, and incubated at 30°C for 18 hours. If precipitation was observed, the reaction mixture was centrifuged for 5 minutes at 15,000 rpm. The precipitates were washed twice with distilled water and then dissolved in 1.0ml of DMSO.The DMSOsolution was divided into two halves which were used for determination of the calcium and pradimicin contents by atomic absorption spectrometry and visible spectrophotometry at 498.4 nm, respectively5^The molar ratio of Ca2+: Pradimicin was calculated from the contents of Ca2+ and pradimicin in the DMSOsolution.
In Vitro Antifungal Assay: MICon Candida albicans A9540 was determined by serial dilution in YNBG-PBliquid medium (Difco), pH 7.0, in the presence of 200 yM calcium chloride5).
Potassium Leakage Induction Test: Candida albicans A9540 was cultivated and harvested as described in a previous paper5). One milliliter of the yeast cell suspension (5 x 107 cells) was mixed with 100/xl of a pradimicin solution, 10 /il of 100mMcalcium chloride and 890/il of physiological saline. After incubation at 30°C for 2 hours, the cells and the supernatant were separated by centrifugation at 15,000 rpm and 4°C for 10 minutes. The control test was run without pradimicin derivative.
The supernatant solution was directly subjected to measurement of the potassium content by atomic absorption spectrometry. The control cells were boiled for 10 minutes at 100°C for release of the total amount of potassium into the supernatant which was subjected to atomic absorption spectrometry. In the control test, a reference potassium content of 23.2ppm/5 x 107 cells was obtained and employed at 100% for calculation of the percent potassium leakage. BMY-28754: Thionyl chloride (3 ml) was dropwise added to a stirred solution of 290mg pradimicin A in 50ml of ethanol, and was stirred for one hour at 0°C and then for a further two hours at room temperature. After concentration to dryness in vacuo, the residue was subjected to reversed-phase silica gel column chromatography (ODS-A60, Yamamura Chemical Lab., 2.0 x 32 cm). Products were eluted by increasing stepwise the concentration of acetonitrile in 0.15% KH2PO4, pH 3.5, starting with the ratio of 2:8 and ending with the ratio of 1 : 1. Eluate fractions containing BMY-28754were combined and concentrated under reduced pressure for removal of the organic solvent. The aqueous concentrate was applied on a Diaion HP-20 column for desalting. After rinsing with distilled water, the product was eluted with 80% aqueous acetone (pH 3.0 with HC1). Concentration of the red eluate to dryness yielded 263mg BMY-28754 hydrochloride.
MP 218~221°C (dec). BMY-28946 (Desxylosyl BMY-28864) and BMY-28962 (BMY-28864 Aglycone): A solution of 50 mg BMY-28864in a mixture of5ml ofdioxane and 1 ml of 1n HC1was heated for 8 hours on a steam bath and then neutralized with 1 n NaOH.After the dioxane was removed by evaporation in vacuo, the remaining aqueous solution was charged on a Diaion HP-20 chromatographic column (1.8 x 25 cm). The column was rinsed with water and eluted with 80%aqueous acetone, pH 3.0. Evaporation of the solvent in vacuo gave a deep red solid which was subjected to successive purification by reversed-phase silica gel column BMY-28634 (pradimicin AG-1 1 or B), BMY-28749 (pradimicin AG-1) and BMY-28750 (pradimicin AG-2) were prepared as described in a previous paper8). Using BMY-28864and structurally-related pradimicin derivatives (see Fig. 1 ), the calcium-binding site of BMY-28864 was analysed first. As the terminal C-18 carboxyl group and the 4 hydroxyl groups of the aglycone of BMY-28864 were taken into account as possible calcium-binding sites, the calcium salt-forming abilities of the pradimicin derivatives were examined in the absence of mannan as the sugar component.
It is obvious from Table 1 that only the free C-18 carboxyl group of BMY-28864 is responsible for binding to calcium, as the pradimicin alkyl esters (BMS-184497, BMY-28754 and BMY-28749) form no calcium salts, whereas the other pradimicin derivatives, which all possess the free C-18 carboxyl group, yield the calcium salts at a molar Ca2+/pradimicin ratio of 1 :2. This molar ratio is identical with that observed in the ternary complex of BMY-28864with methyl a-D-mannopyranoside and calcium5), showing that the carboxyl group of the pradimicin derivatives stoichiometrically forms the salt with calcium. Consequently, at least as far as BMY-28864is concerned, it is unambiguously ruled out that any one of the hydroxyl groups of the aglycone is responsible for binding to calcium. It also seems unlikely that pradimicin and benanomicin derivatives other than BMY-28864have different calcium-binding sites other than the free C-18 carboxyl group. It is interesting to note that the presence and configurations of the C-2 and C-4 hydroxyl groups of hexose determine precipitability of the pradimicin derivative in the form of ternary complex. As previously reported5'9), coexistence of BMY-28864or a pradimicin derivative with mannan and calcium induces the upward shift of the visible absorption maximumaround 500 nm which is related to the characteristic red color of the benzo[a]naphthacenequinone ring structure. Fig. 2 shows the UV-visible absorption spectra of BMY-28864with calcium in the presence and absence of mannan. Spectrophotometric effect of mannan is apparent from shift of the visible absorption maximumof BMY-28864from 499nm to 516nm.
Detailed effects of mannan addition on the UV-visible absorption profile of BMY-28864are summarized as follows:
(a) Visible absorption peak of BMY-28864 shifts from 499 to 516nm; (b) a shoulder is generated around 560nm; (c) visible absorption intensity increases in a range of 300 to 440nm; (d) visible absorption intensity decreases in a range of 440 to 510nm; (e) UV absorption intensity decreases below 300nm. Methyl a-D-mannopyranoside produced a spectrum nearly identical to that of mannan (spectrum not shown), but differed in markedly low absorption below 300 nm. Among these characteristics, the visible absorption maximum shift around 500 nmwas selected as a general index to characterize the sugar-recognizing property of pradimicin derivatives in this paper.
(2) Reliability of the Visible Absorption MaximumShift of BMY-28864. Reliability of the visible absorption maximum shift of BMY-28864 as a dependable measure for As the water-solubility greatly differs amongthe pradimicin derivatives employed, the sugar-dependent pradimicin precipitability is an unreliable measurefor comparative analysis of the sugar-recognizing and/or sugar-binding abilities of pradimicin and benanomicin derivatives. Spectrophotometric maximumshift data, in contrast, were found to be dependable with good reproducibility, as they are not limited by water-solubility difference among the pradimicin derivatives. Results in Table 2 apparently demonstrate that the disaccharide moiety at C-5 is essential for the visible absorption maximumshift (and probably for precipitation resulting from ternary complex formation) (compare BMY-28962 and BMY-28750with As benanomicin compounds in which the thomosamine moiety of the pradimicin analogs is replaced by D-fucose were also reported to show a visible absorption maximumshift9), the type of the C-4' substitute (the unsubstituted or substituted amino group versus the hydroxyl group) seems least important in the sugar-recognizing ability of the pradimicin derivatives.
It is worth mentioning that BMS-184497 (BMY-28864 methyl ester), BMY-28749 and BMY-28754 give about half (8~ll nm) the visible absorption maximumshift breadth (16nm) as observed with BMY-28864. This clear difference in the breadth of visible absorption maximumshift served as an impetus to the subsequent study which will prove the important role of calcium in the visible absorption peak shift inducibility1 0). The sugar-recognizing and/or the sugar-binding abilities of BMY-28864are currently summarized as (b) In the two sugar constituents of the C-5 disaccharide moiety, the thomosamine is indispensable, while the D-xylose seemsto be unimportantly involved in sugar recognition. (c) As benanomicin derivatives were reported to generate the visible absorption maximumshift9), the 4'-amino group (substituted or unsubstituted) of the thomosamine moiety is considered to play an insignificant role in sugar recognition. In other words, as far as the axial configuration is retained at C-4', a hydroxyl, amino or substituted amino group can similarly play the essential function for recognition of specific sugars. Consistent Relationship of the Antifungal Activity and Potassium Leakage Induction Data with the Structural Requirement Data for Calcium Salt Formation and Sugar Recognition In previous papers2>3>5), the close relationship among pradimicin derivatives of antifungal activity and potassium leakage data with cell adsorption data was repeatedly pointed out. For example, the time course of BMY-28864-dependent potassium leakage from Candida albicans A9540 in Fig. 6 shows the dose dependency of potassium leakage on the BMY-28864concentration in the presence of calcium. Table 3 collectively compares the antifungal activity, calcium salt formability, absorption peak shift inducibilitv and notassium leakaee inducibilitv of BMY-28864 and the structurallv related derivatives. In summary, the following conclusions are drawn from Table 3 : Pradimicin derivatives which have no free C-18 carboxyl group (or no site for binding to calcium)
(BMS-184497, BMY-28754 and BMY-28749), even though they can recognize and bind to Dmannopyranoside, are also devoid of potassium leakage inducibility and antifungal activity, presumably because, without calcium salt formability, the pradimicin derivatives cannot stay fixed on the yeast cell wall; or high concentrations of pradimicin and calcium are not generated locally on the yeast cytoplasmic membranefor expression of antifungal activity. Pradimicin derivatives which have both of the sugar-recognizing and binding ability and the calcium salt-forming ability (BMY-28864, BMY-28567, BMY-28946 and BMY-28634) express antifungal activity through some lethal actions such as potassium leakage induction as a result of ternary complex formation. pradimicin derivatives such as BMY-28864. The lipophilicity of pradimicin is largely ascribed to the pradimicin aglycone, whereas the disaccharide and amino acid moieties are intrinsically hydrophilic. Accordingly the overall lipophilicity or hydrophilicity of a pradimicin derivative results from the delicate total balance in solubility among the aglycone, the disaccharide moiety and the amino acid substituent. In practice, the pradimicin derivatives of this study greatly differ in water-solubility, which made it unacceptable to employprecipitability of a pradimicin derivative as a comparative measure for ternary complex formation. Under such circumstances, the UV-visible spectrophotometric characteristics of BMY-28864were examined in search for a general measure to evaluate the ternary complex-forming ability. As detailed in the text, although the generation of a shoulder and the intensity change in spectrophotometric absorption are also observed before and after mannanaddition, the visible absorption peak shift of ca. 16nmwas considered to be an appropriate replacement measure for precipitability to demonstrate comparatively the ternary complex-forming ability. For detailed study on the mode of antifungal action of pradimicin derivatives and for further chemical derivation work, it was very interesting and urgent to identify clearly the calcium-and sugar-binding sites of BMY-28864and other pradimicin derivatives, as the ternary complex formation is now assumed to be of absolute necessity for antifungal activity. From chemical viewpoints, some of the hydroxyl groups of the aglycone seemed to be acidic in nature and so to have a potential calcium salt-forming ability. Contrary to the authors' speculation, at least as far as the BMY-28864-related compoundsare concerned, only the C-1 8 carboxyl group is responsible for calcium salt formation, whereas the hydroxyl groups of the aglycone probably have no effect as the alkyl esters produced no calcium salt. As reported in a previous paper5), it is believed that BMY-28864and pradimicin and benanomicin derivatives, although not proteinaceous, behave like lectin, which means their sugar-binding pocket meets spacial or environmental requirements necessary for specific-sugar recognition and binding. To date, all pradimicin derivatives seem to be specific for mannose, but it cannot be explicitly ruled out that, as the antifungal activity has very often been focused on Candida whose mannan is best suited for binding to pradimicin compounds, other types of pradimicin derivatives that recognize and bind to sugars other than mannose might have been left unnoticed as antifungally inactive derivatives. For now it seems reasonable to think that BMY-28864 and the antifungally active derivatives of this paper share the mannose-specific sugar binding characteristics. More particularly, the pradimicin aglycone and the thomosamine moiety of BMY-28864 serve to construct a specific mannose-binding pocket which stereospecifically recognizes and accommodatestwo moles of D-mannopyranoside. Lectins, on the other hand, are knownto vary widely in specific-sugar recognition. Amongwell-characterized lectins, however, mannose-binding lectins such as concanavalin A and Pisum sativum lectin are assumed to be worth comparing with pradimicin derivatives, because the special requirements for the D-mannopyranoside-recognizing site would be at least partially equivalent. It is regrettable to say that no crystallographic data have yet been obtained for BMY-28864and other pradimicin derivatives. Structure-antifungal activity relationship study in this paper clearly demonstrates that, although there remains much to be studied, antifungally active pradimicin derivatives should have both the xylosyl-thomosamine moiety (at least the thomosamine moiety) at C-5 for recognition of and binding to mannan; and the free carboxyl group at C-18 for calcium salt formation. Once the spacial requirements for ternary complex formation of BMY-28864are elucidated, more detailed and fruitful discussions will becomepossible about the substituents of the pradimicin aglycone for design of more clinically useful pradimicin derivatives.
In the meantime, BMY-28864methyl ester or BMS-184497gives a narrower breadth of absorption peak shift (ca. 8nm) than BMY-28864in the presence of mannan and calcium (Table 3) . As the C-18 carboxyl group is protected by methyl, BMY-28864methyl ester has no chance to form calcium salt, but its aglycone and disaccharide moiety are exactly the same as BMY-28864. Thus it is theoretically assumable that BMY-28864methyl ester still retains the mannan-recognizing ability regardless of no calcium salt-forming ability. MAR. 1993 This hypothesis is the starting point of the subsequent paper which will describe the reaction sequence analysis of ternary complex formation under more critical analytical conditions.
